These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 29697201)

  • 41. miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
    You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
    DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4.
    Wang Q; Selth LA; Callen DF
    Oncotarget; 2017 May; 8(18):29914-29924. PubMed ID: 28430625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
    Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
    Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
    Zhang H; Lu J; Jiang C; Lu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).
    Song L; Li Y; Li W; Wu S; Li Z
    J Cell Biochem; 2014 Jul; 115(7):1234-42. PubMed ID: 24038379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
    Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
    Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-144 reverses cisplatin resistance in cervical cancer via targeting LHX2.
    Shi F; Su J; Liu Z; Wang J; Wang T
    J Cell Biochem; 2019 Sep; 120(9):15018-15026. PubMed ID: 31017720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The negative feedback between miR-143 and DNMT3A regulates cisplatin resistance in ovarian cancer.
    Han X; Liu D; Zhou Y; Wang L; Hou H; Chen H; Zhang L; Chen W; Li X; Zhao L
    Cell Biol Int; 2021 Jan; 45(1):227-237. PubMed ID: 33090550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting KLF6 and KLF15.
    Wang K; Ren Y; Liu Y; Zhang J; He JJ
    Oncol Res; 2017 Jan; 25(2):277-283. PubMed ID: 27629257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through
    Vera O; Jimenez J; Pernia O; Rodriguez-Antolin C; Rodriguez C; Sanchez Cabo F; Soto J; Rosas R; Lopez-Magallon S; Esteban Rodriguez I; Dopazo A; Rojo F; Belda C; Alvarez R; Valentin J; Benitez J; Perona R; De Castro J; Ibanez de Caceres I
    Theranostics; 2017; 7(17):4118-4134. PubMed ID: 29158814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
    Ahmad A; Zhang W; Wu M; Tan S; Zhu T
    Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
    Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
    Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
    Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
    Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
    Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
    Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.